Mimedx MDXG
NASDAQ MDXG
$4.51 -0.16 (-3.53%)
As of: Sep 10, 2026 · 12:40 PM EDT

Mimedx (MDXG) Total Non-Current Liabilities (2010 - 2026)

Mimedx's (MDXG) quarterly Total Non-Current Liabilities came in at $54.2 million in Q2 2026, down 19.7% year-over-year from $67.5 million in Q2 2025, and down 10.62% quarter-over-quarter from $60.6 million in Q1 2026.

Analysis

Mimedx (MDXG) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Mimedx has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $54.2 million for Q2 2026.

  • In Q2 2026, Total Non-Current Liabilities fell 19.7% year-over-year to $54.2 million; the TTM figure through Jun 2026 stood at $54.2 million (down 19.7% YoY), while the FY2025 annual figure was $80.7 million, up 27.29% from the prior year.
  • Total Non-Current Liabilities came in at $54.2 million for Q2 2026 at Mimedx, down from $60.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $94.3 million in Q3 2022 to a low of $54.2 million in Q2 2026.
  • Average Total Non-Current Liabilities over 5 years is $75.9 million, with a median of $77.6 million recorded in 2025.
  • Year-over-year, Total Non-Current Liabilities sank 37.55% in 2024 and advanced 27.29% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $92.2 million in 2022, then grew by 2.12% to $94.1 million in 2023, then sank by 32.6% to $63.4 million in 2024, then rose by 27.29% to $80.7 million in 2025, then sank by 32.86% to $54.2 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $54.2 million in Q2 2026, $60.6 million in Q1 2026, and $80.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn -
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn 40.46 Bn
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 2.57 Bn
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn 3.68 Bn
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn 3.44 Bn
10 Mimedx 667.30 Mn 531.46 Mn 44.38 Mn 54.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.20 Mn
Mar 31, 2026 60.64 Mn
Dec 31, 2025 80.73 Mn
Sep 30, 2025 74.52 Mn
Jun 30, 2025 67.50 Mn
Mar 31, 2025 60.15 Mn
Dec 31, 2024 63.43 Mn
Sep 30, 2024 59.96 Mn
Jun 30, 2024 58.26 Mn
Mar 31, 2024 60.67 Mn
Dec 31, 2023 94.11 Mn
Sep 30, 2023 92.59 Mn
Jun 30, 2023 93.30 Mn
Mar 31, 2023 89.58 Mn
Dec 31, 2022 92.15 Mn
Sep 30, 2022 94.33 Mn
Jun 30, 2022 85.49 Mn
Mar 31, 2022 84.83 Mn
Dec 31, 2021 90.48 Mn
Sep 30, 2021 89.76 Mn